Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.56 |
| ▸ | ESRRB | O95718 | 1/20 | 0.54 |
| ▸ | ESR1 | P03372 | 1/20 | 0.54 |
| ▸ | ESRRA | P11474 | 1/20 | 0.54 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.54 |
| ▸ | DHODH | Q02127 | 1/20 | 0.53 |
| ▸ | ACACA | Q13085 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | TOP1 | P11387 | 1/20 | 0.47 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7259981 | 0.90 | ACHE (0.47) | ACHELMNASMN1; SMN2KDM4EHPGD | |
| SCHEMBL1758675 | 0.83 | MAPK1 (0.52) | ACHESMN1; SMN2KDM4EHPGDESRRB | |
| SCHEMBL29399315 | 0.79 | ACACA (0.72) | ACHELMNASMN1; SMN2KDM4EHPGD | |
| SCHEMBL1042853 | 0.79 | ACACA (0.72) | ACHELMNASMN1; SMN2KDM4EHPGD | |
| SCHEMBL29400688 | 0.78 | ACACA (0.65) | ACHELMNASMN1; SMN2KDM4EHPGD | |
| SCHEMBL28251703 | 0.78 | ACACA (0.65) | ACHELMNASMN1; SMN2KDM4EHPGD | |
| SCHEMBL969768 | 0.78 | ACACA (0.65) | ACHELMNASMN1; SMN2KDM4EHPGD | |
| SCHEMBL4594838 | 0.78 | ACACA (0.75) | ACHELMNASMN1; SMN2KDM4EHPGD | |
| SCHEMBL16990162 | 0.78 | ACACA (0.70) | ACHELMNASMN1; SMN2KDM4EHPGD | |
| SCHEMBL6631411 | 0.77 | ACHE (0.58) | ACHELMNASMN1; SMN2KDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101280186-A | Photophosphorescence material contain iridium complex of phenylquinoline and acidamide group and preparation thereof | UNIV JIANGNAN (CN) | 2008-10-08 | — | — | CN | claimed |
| US-11785844-B2 | Organic light emitting device, method for manufacturing same and composition for organic material layer | LT MATERIALS CO., LTD. (KR) | 2023-10-10 | — | — | US | disclosed |
| US-11785844-B2 | Organic light emitting device, method for manufacturing same and composition for organic material layer | LT MATERIALS CO., LTD. (KR) | 2023-10-10 | — | — | US | disclosed |
| CN-115521253-B | Bibiquinoline derivative compound and application thereof | 烟台显华科技集团股份有限公司 | 2023-04-07 | — | — | CN | disclosed |
| CN-115521253-A | Bibiquinoline derivative compound and application thereof | 烟台显华科技集团股份有限公司 | 2022-12-27 | — | — | CN | disclosed |
| US-11527723-B2 | Heterocyclic compound and organic light emitting element comprising same | LT MATERIALS CO., LTD. (KR) | 2022-12-13 | — | — | US | disclosed |
| WO-2022239930-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE | 엘티소재주식회사 | 2022-11-17 | — | — | WO | disclosed |
| US-11387418-B2 | Organic light emitting element and composition for organic material layer in organic light emitting element | LT MATERIALS CO., LTD. (KR) | 2022-07-12 | — | — | US | disclosed |
| EP-3604298-B1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | LT MATERIALS CO LTD (KR) | 2022-03-30 | — | — | EP | disclosed |
| WO-2021235820-A1 | ORGANIC LIGHT-EMITTING DEVICE | 엘티소재주식회사 | 2021-11-25 | — | — | WO | disclosed |
| US-7632845-B2 | 2-(p-oxyphenyl)-6-oxyquinolines, e.g., 2-(3-Fluoro-4-hydroxyphenyl)-4-phenylquinolin-6-ol; inflammatory bowel disease; Crohn's disease; anticarcinogenic agents; anticholesterol agents; antilipemic agents; cardiovascular diorders; osteoporosis; A lzheimer's disease; fertility; antiarthritic agents | WYETH (US) | 2009-12-15 | — | — | US | disclosed |
| CN-101280186-A | Photophosphorescence material contain iridium complex of phenylquinoline and acidamide group and preparation thereof | UNIV JIANGNAN (CN) | 2008-10-08 | — | — | CN | disclosed |
| US-20060217399-A1 | Phenyl quinolines and their use as estrogenic agents | WYETH (US) | 2006-09-28 | — | — | US | disclosed |
| CN-1823046-A | Phenyl quinolines and their use as estrogen receptor modulators | WYETH CORP (US) | 2006-08-23 | — | — | CN | disclosed |
| US-7084276-B2 | Phenyl quinolines and their use as estrogenic agents | WYETH (US) | 2006-08-01 | — | — | US | disclosed |
| EP-1628961-A1 | PHENYL QUINOLINES AND THEIR USE AS ESTROGEN RECEPTOR MODULATORS | Wyeth (US) | 2006-03-01 | — | — | EP | disclosed |
| US-20050009784-A1 | Phenyl quinolines and their use as estrogenic agents | WYETH | 2005-01-13 | — | — | US | disclosed |
| WO-2004103973-A1 | PHENYL QUINOLINES AND THEIR USE AS ESTROGEN RECEPTOR MODULATORS | WYETH (US) | 2004-12-02 | — | — | WO | disclosed |
| US-4788204-A | TRANQUILIZERS; ANTICONVULSANTS; ANGINA AND IMMUNODIFICIENCY TREATMENTS | RHONE-POULENC SANTE (FR) | 1988-11-29 | — | — | US | disclosed |
| US-4788199-A | ANXIOLYTICS, ANTICONVULSANTS, ANTIANGINA AGENTS | RHONE-POULENC SANTE (FR) | 1988-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11387418-B2 | Organic light emitting element and composition for organic material layer in organic light emitting element | CRY1, CYBA, L1CAM | ACHE 978/4885LMNA 947/4885SMN1; SMN2 3849/4885 |
| US-20050009784-A1 | Phenyl quinolines and their use as estrogenic agents | ESR1, GPER1, ESR2 | ACHE 837/4885LMNA 3392/4885SMN1; SMN2 4647/4885 |
| US-20060217399-A1 | Phenyl quinolines and their use as estrogenic agents | ESR1, GPER1, ESR2 | ACHE 837/4885LMNA 3392/4885SMN1; SMN2 4647/4885 |
| US-11527723-B2 | Heterocyclic compound and organic light emitting element comprising same | CRY1, CRY2, CYP1A1 | ACHE 1269/4885LMNA 3451/4885SMN1; SMN2 3668/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.